---All---
  • ---All---
  • Accession
  • Catalog #

RNF103 Antibody (Center)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP16642c 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP16642c-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

RNF103 Antibody (Center) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionO00237
Other AccessionQ9EPZ8, Q9R1W3, NP_005658.1
ReactivityHuman
PredictedMouse, Rat
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW79405 Da

RNF103 Antibody (Center) - Additional info

Gene ID 7844
Other Names
RNF103; ZFP103; E3 ubiquitin-protein ligase RNF103; KF-1; RING finger protein 103; Zinc finger protein 103 homolog
Target/Specificity
This RNF103 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 205-234 amino acids from the Central region of human RNF103.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
RNF103 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.

RNF103 Antibody (Center) - Protein Information

Name RNF103
Synonyms ZFP103
Function
Acts as an E2-dependent E3 ubiquitin-protein ligase, probably involved in the ER-associated protein degradation pathway
Cellular Location
Endoplasmic reticulum membrane; Multi-pass membrane protein
Tissue Location
Highly expressed in the normal cerebellum but not in the cerebral cortex

RNF103 Antibody (Center) - Related products

AP16642c: RNF103 Antibody (Center)

RI14562: RNF103 predesign siRNA

DC06840: Human RNF103 cDNA Clone

AT3656a: RNF103 Antibody (monoclonal) (M01)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

The protein encoded by this gene contains a RING-H2 finger, a motif known to be involved in protein-protein and protein-DNA interactions. This gene is highly expressed in normal cerebellum, but not in the cerebral cortex. The expression of the rat counterpart in the frontal cortex and hippocampus was shown to be induced by elctroconvulsive treatment (ECT) as well as chronic antidepressant treatment, suggesting that this gene may be a molecular target for ECT and antidepressants. The protein is a ubiquitin ligase that functions in the endoplasmic reticulum-associated degradation pathway. Alternative splicing of this gene results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream VPS24 (vacuolar protein sorting 24 homolog) gene. [provided by RefSeq].

REFERENCES

Scheper, J., et al. Proteins 74(1):92-103(2009) Maruyama, Y., et al. Biochem. Biophys. Res. Commun. 374(4):737-741(2008) Yang, Y., et al. Meth. Enzymol. 398, 103-112 (2005) : Nishioka, G., et al. J Neural Transm 110(3):277-285(2003) Yamada, M., et al. Biochem. Biophys. Res. Commun. 278(1):150-157(2000)